- List
- By Topic
- On Map
- Search Details

stem cells AND cancer
Need help? See RSS Feeds
Choose a feed type:

stem cells AND cancer (4324 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT01483001 | Completed | Feasibility Study on Stem Cells Sensitivity Assay |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
23 | All | 18 Years and older (Adult, Older Adult) | NCT01483001 | LIVONCO 2011/001 2011-003421-10 |
STELLA | November 2011 | September 2012 | December 2013 | December 1, 2011 | January 14, 2015 |
|
||
2 | NCT01641003 | Unknown † | Isolation and Characterization of Cancer Stem Cells Using iFP Technique |
|
Observational |
|
Other |
|
|
15 | All | 18 Years and older (Adult, Older Adult) | NCT01641003 | cancer stem cells.ctil | July 2012 | June 2014 | June 2015 | July 16, 2012 | July 16, 2012 |
|
|||||
3 | NCT02115958 | Completed | The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
40 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT02115958 | CLN-001 201401 |
March 2014 | May 2015 | May 2015 | April 16, 2014 | June 3, 2015 |
|
|||
4 | NCT02074046 | Completed | Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
40 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT02074046 | CLP-001 201401 |
February 2014 | March 2015 | March 2015 | February 28, 2014 | June 3, 2015 |
|
|||
5 | NCT02084823 | Completed | Vaccine Therapy in Treating Lung Cancer Patients With Cancer Stem Cells |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
40 | All | 20 Years to 80 Years (Adult, Older Adult) | NCT02084823 | CLL-001 201401 |
March 2014 | October 2014 | December 2014 | March 12, 2014 | June 3, 2015 |
|
|||
6 | NCT02089919 | Completed | Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
40 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT02089919 | CLH-001 201401 |
February 2014 | February 2015 | February 2015 | March 18, 2014 | June 3, 2015 |
|
|||
7 | NCT02176746 | Completed | A Phase I/II Study of Active Immunotherapy With Cancer Stem Cells Vaccine for Colorectal Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
40 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT02176746 | CLC-001 | CSC | June 2014 | May 2015 | May 2015 | June 27, 2014 | June 3, 2015 |
|
||
8 | NCT02530047 | Active, not recruiting | Mesenchymal Stem Cells (MSC) for Ovarian Cancer |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
5 | Female | 18 Years to 90 Years (Adult, Older Adult) | NCT02530047 | 2013-0032 CA 136411 NCI-2015-01504 |
May 16, 2016 | May 2019 | May 2019 | August 20, 2015 | July 9, 2018 |
|
|||
9 | NCT01286883 | Terminated | Cancer Stem Cell Markers and Prognostic Markers in Circulating Tumor Cells |
|
Observational |
|
Other |
|
|
33 | All | 18 Years and older (Adult, Older Adult) | NCT01286883 | PSHCI 10-066 PSHMC IRB No. 34902EP |
February 2011 | February 2014 | September 2014 | January 31, 2011 | August 20, 2018 |
|
|||||
10 | NCT01190345 | Completed | Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab and Chemotherapy in Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
75 | Female | 18 Years and older (Adult, Older Adult) | NCT01190345 | AVASTEM/IPC 2009-001 | AVASTEM | May 2010 | July 24, 2012 | October 6, 2017 | August 27, 2010 | August 13, 2018 |
|
||
11 | NCT01983709 | Terminated | Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
7 | Male | 18 Years to 100 Years (Adult, Older Adult) | NCT01983709 | J1348 NA_00083720 |
MSC | October 2013 | June 2017 | June 2017 | November 14, 2013 | July 16, 2018 |
|
||
12 | NCT00429572 | Completed Has Results |
Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
19 | All | 18 Years to 60 Years (Adult) | NCT00429572 | DM97-268 | January 1998 | May 2008 | May 2008 | January 31, 2007 | August 7, 2012 | July 13, 2011 |
|
||
13 | NCT02178670 | Completed | Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells Vaccine |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
40 | Female | 18 Years to 75 Years (Adult, Older Adult) | NCT02178670 | CLO-001 201401 |
June 2014 | April 2015 | April 2015 | July 1, 2014 | June 3, 2015 |
|
|||
14 | NCT00405327 | Completed | A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
16 | All | up to 30 Years (Child, Adult) | NCT00405327 | UMCC 2005.050 GCRC ID # 2191 HUM00002650 |
June 2006 | June 2009 | June 2010 | November 30, 2006 | November 6, 2017 |
|
|||
15 | NCT01075893 | Completed | Changes in Stem Cells of the Colon in Response to Increased Risk of Colorectal Cancer |
|
Observational |
|
Other |
|
|
11 | All | 18 Years to 85 Years (Adult, Older Adult) | NCT01075893 | McCallum-001 | February 2010 | October 2012 | October 2012 | February 25, 2010 | October 31, 2017 |
|
|||||
16 | NCT00610415 | Completed | Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study |
|
|
Observational |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Older Adult) | NCT00610415 | ENT0023 98543 SU-12142007-934 10514 |
December 2007 | October 2012 | February 8, 2008 | July 1, 2016 |
|
|||||
17 | NCT00003432 | Terminated | Immunotherapy in Treating Patients With Metastatic Breast Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / NIH |
|
|
4 | All | 18 Years and older (Adult, Older Adult) | NCT00003432 | 2030 IRB 2030 CDR0000066458 |
June 1998 | November 2002 | November 2002 | April 25, 2003 | November 6, 2013 |
|
|||
18 | NCT00429507 | Completed Has Results |
Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases |
|
|
Interventional |
Phase 2 |
|
Other / Industry |
|
|
12 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT00429507 | 2006-0349 NCI-2010-00573 |
March 2007 | November 2014 | November 2014 | January 31, 2007 | November 24, 2015 | November 24, 2015 |
|
||
19 | NCT03407040 | Enrolling by invitation | Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy |
|
Observational |
|
NIH |
|
|
79 | All | 16 Years to 100 Years (Child, Adult, Older Adult) | NCT03407040 | 180043 18-C-0043 |
January 30, 2018 | December 31, 2028 | December 31, 2030 | January 23, 2018 | December 18, 2018 |
|
|||||
20 | NCT01374841 | Recruiting | Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
20 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT01374841 | IEO S513/110 2009-018083-94 |
August 2010 | August 2019 | December 2019 | June 16, 2011 | September 20, 2018 |
|
|||
21 | NCT03632798 | Recruiting | Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
300 | Female | 18 Years and older (Adult, Older Adult) | NCT03632798 | CG02EOC | ACSCO | August 1, 2018 | July 30, 2021 | January 31, 2022 | August 15, 2018 | January 8, 2019 |
|
||
22 | NCT02570100 | Recruiting | Research and Analysis of the Mechanisms Involved in the Emergence of Breast Cancer Stem Cells (RepriM) |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
100 | Female | 18 Years and older (Adult, Older Adult) | NCT02570100 | RepriM-1407 | April 2015 | October 2017 | September 2020 | October 7, 2015 | July 28, 2016 |
|
|||
23 | NCT00281879 | Terminated Has Results |
Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
200 | All | up to 60 Years (Child, Adult) | NCT00281879 | CDR0000452794 P30CA016058 OHSU-TPI-9695-L OHSU-540 |
February 2006 | February 2008 | March 2008 | January 25, 2006 | September 27, 2017 | June 19, 2012 |
|
||
24 | NCT01424865 | Unknown † | Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial |
|
|
Observational |
|
Other / NIH |
|
|
1874 | Female | 18 Years and older (Adult, Older Adult) | NCT01424865 | NSABP B-31 ICSCA NSABP-B31-ICSC-A |
November 2011 | December 2015 | August 29, 2011 | May 8, 2015 | ||||||
25 | NCT03626285 | Recruiting | Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Participants With Cancer or Other Disorders |
|
|
Interventional |
Not Applicable |
|
Other / NIH |
|
|
20 | All | up to 70 Years (Child, Adult, Older Adult) | NCT03626285 | IRB00010804 NCI-2018-00556 P30CA069533 |
August 6, 2017 | December 31, 2020 | December 31, 2020 | August 13, 2018 | August 13, 2018 |
|
|||
26 | NCT00141765 | Completed Has Results |
Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
25 | All | up to 21 Years (Child, Adult) | NCT00141765 | UMCC 9626 IRB 1996-195 |
January 1997 | December 2008 | February 2010 | September 1, 2005 | June 20, 2014 | June 20, 2014 |
|
||
27 | NCT00432094 | Recruiting | Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
25 | All | 10 Years to 69 Years (Child, Adult, Older Adult) | NCT00432094 | 2006LS032 UMN-MT2005-21 UMN-0608M90586 |
December 19, 2006 | January 2020 | January 2020 | February 7, 2007 | February 12, 2019 |
|
|||
28 | NCT00002772 | Terminated | S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer |
|
|
Interventional |
Phase 3 |
|
Other / NIH |
|
602 | Female | 18 Years and older (Adult, Older Adult) | NCT00002772 | CDR0000064747 S9623 U10CA032102 |
July 1996 | February 2004 | February 2004 | April 22, 2004 | January 24, 2013 |
|
||||
29 | NCT00020722 | Terminated Has Results |
Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
7 | Female | 18 Years to 120 Years (Adult, Older Adult) | NCT00020722 | CDR0000068707 P30CA022453 WSU-2007-033 RWMC-0634246 |
August 2007 | March 2013 | March 2013 | January 27, 2003 | February 17, 2016 | March 30, 2015 |
|
||
30 | NCT01231022 | Completed | Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC) |
|
Observational |
|
Other |
|
|
52 | Female | 18 Years to 70 Years (Adult, Older Adult) | NCT01231022 | DILI | MBC | August 2010 | June 2011 | June 2013 | November 1, 2010 | July 29, 2015 |
|
||||
31 | NCT02063893 | Completed | Safety Study of Cancer Stem Cell Vaccinie to Treat Breast Cancer |
|
Observational |
|
Other |
|
|
40 | Female | 30 Years to 75 Years (Adult, Older Adult) | NCT02063893 | CLB-001 201401 |
CSC | January 2014 | January 2015 | February 2015 | February 17, 2014 | June 3, 2015 |
|
||||
32 | NCT01799694 | Completed | Stem Cells Treatment for the Local Urinary Incontinence After a Radical Prostate Cancer Surgery (HULPURO) |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
10 | Male | 18 Years and older (Adult, Older Adult) | NCT01799694 | FLPURO-2009-01 2009-016298-14 |
FLPURO | July 2011 | February 2013 | February 2013 | February 27, 2013 | March 8, 2013 |
|
||
33 | NCT00458653 | Active, not recruiting | Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
45 | All | 18 Years and older (Adult, Older Adult) | NCT00458653 | 04-098 | April 2005 | April 2012 | June 2019 | April 11, 2007 | July 24, 2018 |
|
|||
34 | NCT01445132 | Completed | Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation |
|
|
Interventional |
Phase 1 |
|
NIH |
|
|
11 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01445132 | 070064 07-C-0064 |
January 11, 2007 | April 24, 2013 | April 24, 2013 | October 3, 2011 | July 4, 2018 |
|
|||
35 | NCT02331134 | Recruiting | Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT02331134 | 14-0842.cc | May 13, 2015 | March 2020 | March 2020 | January 6, 2015 | December 3, 2018 |
|
|||
36 | NCT01326728 | Terminated Has Results |
Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation |
|
|
Observational |
|
NIH |
|
|
56 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT01326728 | 110125 11-C-0125 |
March 30, 2011 | June 28, 2017 | July 14, 2017 | March 31, 2011 | June 5, 2018 | June 5, 2018 |
|
|||
37 | NCT00006032 | Terminated | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
Female | 18 Years to 64 Years (Adult) | NCT00006032 | MCC-12220 MCC-IRB-5699 NCI-G00-1809 |
March 2000 | April 2001 | April 2001 | April 2, 2004 | December 11, 2012 |
|
|||||
38 | NCT00179803 | Unknown † | Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
50 | All | 18 Months to 25 Years (Child, Adult) | NCT00179803 | BMT 0398 | March 1998 | January 2008 | September 16, 2005 | March 14, 2011 |
|
||||
39 | NCT01678443 | Active, not recruiting Has Results |
Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies |
|
|
Interventional |
Phase 1 |
|
Other / NIH |
|
|
2 | All | 18 Years and older (Adult, Older Adult) | NCT01678443 | 2361.00 NCI-2012-01505 P01CA044991 P30CA015704 |
September 1, 1999 | April 11, 2011 | July 24, 2019 | September 5, 2012 | November 20, 2018 | November 9, 2017 |
|
||
40 | NCT00002836 | Completed | Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer |
|
|
Interventional |
Phase 3 |
|
Other / NIH |
|
|
184 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT00002836 | DM95-047 P30CA016672 MDA-DM-95047 NCI-G96-1014 CDR0000065048 |
September 26, 1995 | March 9, 2006 | March 9, 2006 | November 24, 2003 | November 6, 2018 |
|
|||
41 | NCT00020410 | Completed | Radiolabeled Monoclonal Antibody Followed by Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Metastatic Breast Cancer |
|
|
Interventional |
Phase 1 |
|
NIH |
|
All | 18 Years and older (Adult, Older Adult) | NCT00020410 | CDR0000068405 NCI-00-C-0206 NCI-213 |
February 2001 | January 27, 2003 | April 30, 2015 |
|
|||||||
42 | NCT00004177 | Completed | Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / NIH |
|
|
15 | Female | 18 Years to 80 Years (Adult, Older Adult) | NCT00004177 | CDR0000067299 R03CA077146 CMMI-C-039A-98 NCI-H99-0044 NCI-V99-1570 |
August 1999 | May 2002 | April 16, 2004 | June 22, 2011 |
|
||||
43 | NCT00966498 | Terminated | Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid Tumors |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
3 | All | up to 35 Years (Child, Adult) | NCT00966498 | 1023-2003 PBSCT for ST |
May 2003 | July 2011 | July 2011 | August 27, 2009 | December 11, 2013 |
|
|||
44 | NCT01921387 | Active, not recruiting Has Results |
Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / NIH |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT01921387 | 2728.00 NCI-2013-01378 P01CA044991 P30CA015704 |
October 9, 2013 | July 26, 2017 | July 26, 2021 | August 13, 2013 | September 3, 2018 | September 3, 2018 |
|
||
45 | NCT00423514 | Active, not recruiting | Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / NIH |
|
|
42 | All | up to 54 Years (Child, Adult) | NCT00423514 | 06-125 MSKCC-06125 |
November 2006 | November 2019 | November 2019 | January 18, 2007 | May 7, 2018 |
|
|||
46 | NCT02183805 | Recruiting | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
30 | Female | 18 Years to 65 Years (Adult, Older Adult) | NCT02183805 | SYSUCC-004 | June 2014 | December 2019 | December 2019 | July 8, 2014 | March 1, 2017 |
|
|||
47 | NCT02745756 | Withdrawn | A Combined Cell Therapy Approach to the Treatment of Neuroblastoma |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
0 | All | up to 21 Years (Child, Adult) | NCT02745756 | MCC-17181 | April 14, 2016 | August 21, 2017 | August 21, 2017 | April 20, 2016 | August 30, 2017 | ||||
48 | NCT00002942 | Completed | Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer |
|
|
Interventional |
Phase 3 |
|
Other / NIH |
|
136 | All | 18 Years to 60 Years (Adult) | NCT00002942 | CDR0000065391 CCCWFU-95496 NCI-G97-1145 |
June 1996 | January 2000 | December 2003 | September 3, 2004 | August 10, 2018 |
|
||||
49 | NCT00003943 | Completed | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer. |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
3 | All | 18 Years and older (Adult, Older Adult) | NCT00003943 | CDR0000067136 FCCC-98039 NCI-G99-1535 |
September 1998 | November 2000 | February 2003 | May 3, 2004 | April 17, 2013 |
|
|||
50 | NCT00003927 | Active, not recruiting | Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer |
|
|
Interventional |
Phase 1 |
|
Other / NIH |
|
|
15 | All | 18 Years to 59 Years (Adult) | NCT00003927 | 99002 P30CA033572 CHNMC-IRB-99002 ALZA-CHNMC-IRB-99002 NCI-G99-1527 CDR0000067115 |
April 22, 1999 | January 2019 | January 2019 | December 11, 2003 | March 12, 2018 |
|
|||
51 | NCT00523809 | Terminated Has Results |
Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
5 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT00523809 | 2006-0873 | August 2007 | October 2011 | October 2011 | September 3, 2007 | January 28, 2013 | January 28, 2013 |
|
||
52 | NCT00068523 | Completed | Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies |
|
|
Interventional |
Not Applicable |
|
Other / NIH |
|
|
10 | All | 18 Years and older (Adult, Older Adult) | NCT00068523 | ICC7Y02 P30CA043703 CWRU-ICC-7Y02 |
June 2003 | March 2004 | September 11, 2003 | June 11, 2010 |
|
||||
53 | NCT00002837 | Completed | High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / NIH / Industry |
|
|
21 | All | 15 Years to 60 Years (Child, Adult) | NCT00002837 | DM95-156 P30CA016672 MDA-DM-95156 NCI-V96-1017 CDR0000065052 |
September 1995 | January 2002 | January 2002 | July 1, 2004 | July 31, 2012 |
|
|||
54 | NCT00003972 | Completed | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer |
|
|
Interventional |
Phase 3 |
|
Other / NIH |
|
280 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT00003972 | 1316.00 FHCRC-1316.00 PSOC-1604 NCI-G99-1552 CDR0000067175 |
July 1998 | March 2003 | March 2003 | May 3, 2004 | April 2, 2010 |
|
||||
55 | NCT00003877 | Completed | Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / NIH |
|
30 | Female | 18 Years to 64 Years (Adult) | NCT00003877 | CDR0000067043 P30CA016056 RPCI-DS-9828 CWRU-OSIR-1198 OSIRIS-101 NCI-G99-1516 |
September 1998 | February 2000 | December 2000 | July 16, 2004 | March 7, 2011 |
|
||||
56 | NCT01171469 | Completed | Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
8 | All | Child, Adult, Older Adult | NCT01171469 | 2008LS053 0809M48641 |
September 2010 | May 2012 | June 2012 | July 28, 2010 | December 2, 2017 |
|
|||
57 | NCT00510315 | Active, not recruiting | Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant |
|
|
Observational |
|
Other |
|
|
11 | Female | 18 Years to 49 Years (Adult) | NCT00510315 | 07-092 | July 2007 | January 2020 | January 2020 | August 2, 2007 | December 4, 2018 |
|
||||
58 | NCT00003080 | Completed | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer |
|
|
Interventional |
Phase 1 |
|
Other / NIH |
|
Female | 18 Years to 60 Years (Adult) | NCT00003080 | 1144.00 FHCRC-1144.00 NCI-G97-1329 CDR0000065775 |
September 1996 | May 2001 | May 2001 | April 14, 2004 | September 15, 2010 |
|
|||||
59 | NCT00002977 | Completed | Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission |
|
|
Interventional |
Phase 1 |
|
Other / NIH |
|
45 | Female | 18 Years to 60 Years (Adult) | NCT00002977 | 1181.00 NCI-G97-1229 CDR0000065499 |
January 1997 | November 2001 | April 29, 2004 | September 15, 2010 |
|
|||||
60 | NCT00074269 | Terminated Has Results |
Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Metastatic Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
5 | Female | 18 Years to 60 Years (Adult) | NCT00074269 | UCSD-020815 CDR0000343758 |
July 2003 | March 2008 | March 2008 | December 11, 2003 | May 31, 2018 | November 24, 2014 |
|
||
61 | NCT00002784 | Completed | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
344 | Female | 16 Years to 65 Years (Child, Adult, Older Adult) | NCT00002784 | CDR0000064834 IBCSG-15-95 EU-96021 |
15-95 | June 1996 | August 2011 | December 2011 | July 29, 2004 | April 4, 2013 |
|
||
62 | NCT00003297 | Completed | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / NIH |
|
50 | Female | 18 Years and older (Adult, Older Adult) | NCT00003297 | CDR0000066235 P30CA051008 GUMC-97342 NCI-G98-1414 |
December 1997 | January 2001 | January 2001 | July 8, 2004 | March 24, 2011 |
|
||||
63 | NCT00003413 | Completed | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
32 | Female | 18 Years to 70 Years (Adult, Older Adult) | NCT00003413 | CDR0000066426 MSGCC-9749 NCI-V98-1452 |
September 1998 | February 2001 | February 2001 | August 3, 2004 | September 24, 2009 |
|
||||
64 | NCT00605800 | Withdrawn | Bone Marrow Derived Adult Liver Stem Cell Recruitment After Major Liver Resections: Correlation With Liver Regeneration and Hepatic Function |
|
|
Observational |
|
Other / NIH |
|
|
0 | All | 18 Years and older (Adult, Older Adult) | NCT00605800 | 06-017 | March 2006 | March 2009 | March 2009 | January 31, 2008 | March 19, 2009 | |||||
65 | NCT00003136 | Completed | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
11 | Female | up to 65 Years (Child, Adult, Older Adult) | NCT00003136 | 8433 UCCRC-8433 ALZA-97-005-ii NCI-V97-1357 |
December 1996 | December 2000 | October 2001 | August 24, 2004 | February 11, 2013 |
|
|||
66 | NCT01907009 | Unknown † | A PHASEII STUDY EVALUATING INTRAVENOUS MELPHALAN WITH AUTOLOGOUS WHOLE BLOOD STEM CELL TRANSPLANTATION (PBSCT)OVER THREE CYCLES IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (MEL-CAP). |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
39 | Male | 18 Years and older (Adult, Older Adult) | NCT01907009 | MEL-CAP | MEL-CAP | January 2013 | January 2016 | September 2017 | July 24, 2013 | September 9, 2015 |
|
||
67 | NCT00008203 | Completed | Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer |
|
|
Interventional |
Phase 3 |
|
Other / NIH |
|
Female | 18 Years to 65 Years (Adult, Older Adult) | NCT00008203 | CDR0000068387 CPMC-IRB-7608 CPMC-CAMP-014 NCI-G00-1890 |
May 1996 | December 2005 | May 2008 | June 5, 2003 | February 4, 2013 |
|
|||||
68 | NCT00005612 | Terminated | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / NIH |
|
|
3 | Female | 18 Years to 65 Years (Adult, Older Adult) | NCT00005612 | MCC-12085 MCC-IRB-5418 NCI-G00-1745 |
ETC | August 1999 | February 2004 | February 2004 | May 3, 2004 | September 26, 2012 |
|
||
69 | NCT00020176 | Completed | Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer |
|
|
Interventional |
Phase 2 |
|
NIH |
|
All | 18 Years to 70 Years (Adult, Older Adult) | NCT00020176 | CDR0000067899 NCI-00-C-0119 NCI-1027 |
June 2000 | August 2007 | January 27, 2003 | June 20, 2013 |
|
||||||
70 | NCT01341301 | Completed Has Results |
Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
25 | All | 18 Years and older (Adult, Older Adult) | NCT01341301 | 10D.06 2009-41 |
May 2010 | November 4, 2013 | August 7, 2014 | April 25, 2011 | April 25, 2018 | March 16, 2018 |
|
||
71 | NCT01504152 | Completed | International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center |
|
|
Observational |
|
Other |
|
|
519 | All | 18 Years and older (Adult, Older Adult) | NCT01504152 | 11-176 | December 2011 | July 2013 | July 2013 | January 5, 2012 | July 12, 2013 |
|
||||
72 | NCT00003392 | Completed | High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
61 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT00003392 | LCCC 9727 UNC-LCCC-970135 NCI-G98-1446 |
September 1997 | August 2002 | January 2003 | July 22, 2004 | February 22, 2012 |
|
||||
73 | NCT00005993 | Terminated | Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer |
|
|
Interventional |
Phase 1 |
|
Other / NIH |
|
All | 18 Years to 65 Years (Adult, Older Adult) | NCT00005993 | 1999LS022 MT1998-21 NCI-G00-1803 |
May 1999 | July 2005 | July 2005 | June 21, 2004 | November 29, 2017 | ||||||
74 | NCT00004087 | Completed | Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / NIH |
|
|
15 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT00004087 | CDR0000067300 P01CA054425 CMMI-C-033-98 NCI-H99-0042 NCI-V99-1571 |
March 1997 | May 2001 | April 16, 2004 | June 22, 2011 |
|
||||
75 | NCT03023631 | Recruiting | Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant |
|
|
Interventional |
Phase 4 |
|
Other / NIH |
|
|
48 | All | 18 Years and older (Adult, Older Adult) | NCT03023631 | 2016-0714 NCI-2018-02606 P30CA016672 |
April 23, 2017 | April 30, 2019 | April 30, 2019 | January 18, 2017 | November 21, 2018 |
|
|||
76 | NCT03641378 | Recruiting | Inpatient Palliative Care for Patients Undergoing Hematopoietic Stem Cell Transplantation |
|
|
Interventional |
Not Applicable |
|
Other / NIH |
|
|
720 | All | 18 Years and older (Adult, Older Adult) | NCT03641378 | 18-261 R01CA222014 |
September 30, 2018 | July 1, 2022 | July 1, 2023 | August 22, 2018 | December 3, 2018 |
|
|||
77 | NCT00923052 | Terminated | The Natural History of Solid Organ Cancer Stem Cells (SOCSC) |
|
Observational |
|
NIH |
|
|
190 | All | 16 Years to 100 Years (Child, Adult, Older Adult) | NCT00923052 | 090079 09-C-0079 |
February 9, 2009 | May 7, 2015 | June 18, 2009 | February 18, 2019 |
|
||||||
78 | NCT00003064 | Unknown † | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / NIH |
|
30 | Female | 18 Years and older (Adult, Older Adult) | NCT00003064 | CDR0000065734 CPMC-IRB-7866 NCI-G97-1327 |
January 1997 | April 18, 2003 | January 6, 2014 |
|
||||||
79 | NCT00051311 | Completed | Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers |
|
|
Interventional |
Phase 2 |
|
NIH |
|
62 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT00051311 | 030077 03-C-0077 |
January 3, 2003 | September 25, 2014 | September 25, 2014 | January 8, 2003 | February 5, 2019 |
|
||||
80 | NCT00003284 | Unknown † | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
30 | All | Child, Adult, Older Adult | NCT00003284 | CDR0000066206 CPMC-IRB-7836 CU-CAMP-017 NCI-G98-1408 |
January 1998 | August 13, 2004 | January 6, 2014 |
|
||||||
81 | NCT00393341 | Completed | Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer |
|
|
Observational |
|
Other |
|
|
68 | Female | 18 Years and older (Adult, Older Adult) | NCT00393341 | 0609-21 IUCRO-0168 |
EPC | October 2006 | May 2009 | August 2009 | October 27, 2006 | August 31, 2015 |
|
|||
82 | NCT00004900 | Completed | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
Female | 18 Years to 65 Years (Adult, Older Adult) | NCT00004900 | NU-HAC98B2 CDR0000067579 NCI-G00-1689 |
October 1999 | August 2004 | August 20, 2004 | May 30, 2013 |
|
||||||
83 | NCT00004906 | Completed | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
Female | 18 Years to 65 Years (Adult, Older Adult) | NCT00004906 | NU-H97B1 CDR0000067586 NCI-G00-1682 |
October 1999 | June 2001 | August 23, 2004 | May 30, 2013 |
|
||||||
84 | NCT00112593 | Completed Has Results |
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer |
|
|
Interventional |
Not Applicable |
|
Other / NIH |
|
|
5 | All | up to 75 Years (Child, Adult, Older Adult) | NCT00112593 | 1410.00 NCI-2010-00802 P30CA015704 P01CA018029 |
November 1999 | November 2014 | June 3, 2005 | May 24, 2017 | May 24, 2017 |
|
|||
85 | NCT00003680 | Unknown † | Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer |
|
|
Interventional |
Phase 3 |
|
Other |
|
300 | Female | 18 Years to 60 Years (Adult) | NCT00003680 | CDR0000066782 SCTN-BR9810 EU-98054 |
November 1998 | May 3, 2004 | November 6, 2013 |
|
||||||
86 | NCT01139164 | Terminated Has Results |
Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3) |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
78 | All | 1 Year to 75 Years (Child, Adult, Older Adult) | NCT01139164 | 101370 HR#19490 |
June 2010 | September 2014 | December 2015 | June 8, 2010 | July 11, 2018 | March 10, 2016 |
|
||
87 | NCT00262886 | Completed | Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
35 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT00262886 | CDR0000449939 URCC-U1801 URCC-RSRB-09084 |
August 2001 | July 2007 | December 7, 2005 | June 6, 2013 |
|
||||
88 | NCT01440127 | Terminated | Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic Markers |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
9 | All | 18 Years to 79 Years (Adult, Older Adult) | NCT01440127 | Metformin CCSC | August 2011 | October 2012 | October 2012 | September 26, 2011 | March 26, 2015 |
|
|||
89 | NCT00429182 | Completed Has Results |
Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
32 | All | 18 Years to 55 Years (Adult) | NCT00429182 | 2006-0280 | June 2007 | February 2012 | February 2012 | January 31, 2007 | April 10, 2013 | April 10, 2013 |
|
||
90 | NCT00245037 | Completed Has Results |
Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / NIH |
|
|
147 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT00245037 | IRB00000210 P30CA016058 OHSU-HEM-05011-L OHSU-210 |
Bu Flu TBI | June 2005 | August 2015 | August 2015 | October 27, 2005 | September 27, 2017 | July 2, 2017 |
|
|
91 | NCT03032783 | Recruiting | A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
45 | All | 18 Years and older (Adult, Older Adult) | NCT03032783 | 16D.606 | January 31, 2017 | July 24, 2020 | July 24, 2020 | January 26, 2017 | February 20, 2018 |
|
|||
92 | NCT00027573 | Completed | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
36 | All | up to 60 Years (Child, Adult) | NCT00027573 | CALGB-90003 U10CA031946 CDR0000069044 |
October 2001 | June 2006 | June 2006 | January 27, 2003 | July 14, 2016 |
|
|||
93 | NCT00004174 | Completed | Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer |
|
|
Interventional |
Phase 1 |
|
Other / NIH |
|
30 | All | up to 60 Years (Child, Adult) | NCT00004174 | NU 96B1 NU-96B1 NCI-G99-1641 |
October 1999 | May 2008 | May 2008 | April 28, 2004 | July 10, 2013 |
|
||||
94 | NCT00004013 | Completed | Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
60 | All | Child, Adult, Older Adult | NCT00004013 | 1338.00 FHCRC-1338.00 GENENTECH-FHCRC-1338.00 NCI-G99-1557 CDR0000067230 |
January 1999 | October 2001 | October 2001 | April 23, 2004 | April 2, 2010 |
|
||||
95 | NCT00798811 | Completed | High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
100 | All | Child, Adult, Older Adult | NCT00798811 | 2005-12-009 | September 2008 | October 2013 | October 2015 | November 26, 2008 | October 19, 2016 |
|
|||
96 | NCT00004172 | Completed | Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
All | up to 65 Years (Child, Adult, Older Adult) | NCT00004172 | NU 92B3T NU-92B3T NCI-G99-1640 |
October 1999 | October 2003 | October 2003 | September 16, 2004 | June 12, 2012 |
|
|||||
97 | NCT00004048 | Completed | Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
30 | All | 16 Years to 80 Years (Child, Adult, Older Adult) | NCT00004048 | CDR0000067172 CMMI-C-040A-98 CMMI-FDR001555 NCI-V99-1564 |
September 1998 | May 2002 | May 2002 | April 15, 2004 | June 22, 2011 |
|
||||
98 | NCT03712878 | Recruiting | 2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
34 | All | 18 Years and older (Adult, Older Adult) | NCT03712878 | 18D.419 | September 19, 2018 | December 2020 | December 2021 | October 19, 2018 | October 19, 2018 |
|
|||
99 | NCT03531736 | Recruiting | T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Myeloid Malignancies and Aplastic Anemia |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
15 | All | 18 Years and older (Adult, Older Adult) | NCT03531736 | 17-639 | May 9, 2018 | May 2020 | May 2020 | May 22, 2018 | November 20, 2018 |
|
|||
100 | NCT00006968 | Completed | Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / NIH |
|
4 | All | 18 Years and older (Adult, Older Adult) | NCT00006968 | CDR0000068349 UCLA-0001032 SUPERGEN-UCLA-000103201 NCI-G00-1879 |
September 2000 | September 2004 | June 27, 2003 | January 8, 2013 |
|
† Study has passed its completion date and status has not been verified in more than two years.